Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

AC Immune Q1 EPS $(0.21) Misses $(0.20) Estimate, Sales $1.10M Beat $300.67K Estimate

Author: Benzinga Newsdesk | April 30, 2025 09:26am
AC Immune (NASDAQ:ACIU) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.20) by 5 percent. This is unchanged from the same period last year. The company reported quarterly sales of $1.10 million which beat the analyst consensus estimate of $300.67 thousand by 266.19 percent.

Posted In: ACIU


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist